If a diagnosis of TCC of the bladder is suspected, urinary cytology followed by white-light cystoscopy of the bladder is performed. Although white-light cystoscopy is reliable in the detection of ...

Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

White-light cystoscopy is the main method of detecting transitional cell carcinoma of the bladder. Flat carcinoma in situ (CIS) lesions can, however, be difficult to detect with this technique. Fradet ...

The guidelines state that clinicians should offer blue light cystoscopy, if available, as an adjunct to traditional white light cystoscopy (WLC) to increase tumor detection and decrease recurrence.

Bladder cancer affects more than 86,000 people in the United States each year, according to the American Cancer Society, with the majority being over age 55. And while the disease can often be ...

A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...

June 4, 2010 — The US Food and Drug Administration (FDA) has approved hexaminolevulinate HCl (Cysview; GE Healthcare, under license from Photocure ASA) for the detection of non-muscle-invasive ...

Decades ago, blue lights helped shoppers scope out sales. Today they’re helping urologists scope out cells – specifically those of non-muscle-invasive bladder cancer. UW Medicine urologists with ...

OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...

PROVIDENCE — Martin Israelit recently visited The Miriam Hospital. He's being monitored after being diagnosed with bladder cancer. His symptoms began about two years ago. "Those symptoms were blood in ...

In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...